146 related articles for article (PubMed ID: 27630314)
1. Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
Bodner-Adler B; Kimberger O; Schneidinger C; Kölbl H; Bodner K
Anticancer Res; 2016 Sep; 36(9):4691-6. PubMed ID: 27630314
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein is a prognostic parameter in patients with cervical cancer.
Polterauer S; Grimm C; Tempfer C; Sliutz G; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2007 Oct; 107(1):114-7. PubMed ID: 17617445
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of anemia for patients with cervical cancer treated with irradiation].
Grigiene R; Aleknavicius E; Kurtinaitis J
Medicina (Kaunas); 2005; 41(11):916-24. PubMed ID: 16333214
[TBL] [Abstract][Full Text] [Related]
4. Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma.
Bender DP; Sorosky JI; Buller RE; Sood AK
Am J Obstet Gynecol; 2003 Jul; 189(1):113-7. PubMed ID: 12861147
[TBL] [Abstract][Full Text] [Related]
5. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
Schwameis R; Grimm C; Petru E; Natter C; Staudigl C; Lamm W; Koelbl H; Krainer M; Brodowicz T; Reinthaller A; Polterauer S
PLoS One; 2015; 10(8):e0133838. PubMed ID: 26248232
[TBL] [Abstract][Full Text] [Related]
7. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
8. Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis.
Polterauer S; Grimm C; Zeillinger R; Heinze G; Tempfer C; Reinthaller A; Hefler L
Anticancer Res; 2011 Jun; 31(6):2259-64. PubMed ID: 21737650
[TBL] [Abstract][Full Text] [Related]
9. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
[TBL] [Abstract][Full Text] [Related]
11. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.
Alfsen GC; Kristensen GB; Skovlund E; Pettersen EO; Abeler VM
Cancer; 2001 Nov; 92(9):2471-83. PubMed ID: 11745305
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of preoperative serum high sensitivity C-reactive protein in patients with endometrial cancer].
Wang LJ; Zhou H; Lu HW; Li J; Lin ZQ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(41):2927-30. PubMed ID: 22333616
[TBL] [Abstract][Full Text] [Related]
13. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
[TBL] [Abstract][Full Text] [Related]
14. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
16. The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer.
Polterauer S; Grimm C; Seebacher V; Rahhal J; Tempfer C; Reinthaller A; Hefler L
Int J Gynecol Cancer; 2010 Aug; 20(6):1052-7. PubMed ID: 20683416
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of primary adenocarcinoma of the uterine cervix.
Chen RJ; Chang DY; Yen ML; Lee EF; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1998 May; 69(2):157-64. PubMed ID: 9600824
[TBL] [Abstract][Full Text] [Related]
18. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
Gockel I; Dirksen K; Messow CM; Junginger T
World J Gastroenterol; 2006 Jun; 12(23):3746-50. PubMed ID: 16773693
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of adenocarcinoma of the uterine cervix.
Ishikawa H; Nakanishi T; Inoue T; Kuzuya K
Gynecol Oncol; 1999 Apr; 73(1):42-6. PubMed ID: 10094878
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
